Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles
- PMID: 17545589
- DOI: 10.1158/0008-5472.CAN-06-4040
Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles
Abstract
One of the most critical issues in prostate cancer clinic is emerging hormone-refractory prostate cancers (HRPCs) and their management. Prostate cancer is usually androgen dependent and responds well to androgen ablation therapy. However, at a certain stage, they eventually acquire androgen-independent and more aggressive phenotype and show poor response to any anticancer therapies. To characterize the molecular features of clinical HRPCs, we analyzed gene expression profiles of 25 clinical HRPCs and 10 hormone-sensitive prostate cancers (HSPCs) by genome-wide cDNA microarrays combining with laser microbeam microdissection. An unsupervised hierarchical clustering analysis clearly distinguished expression patterns of HRPC cells from those of HSPC cells. In addition, primary and metastatic HRPCs from three patients were closely clustered regardless of metastatic organs. A supervised analysis and permutation test identified 36 up-regulated genes and 70 down-regulated genes in HRPCs compared with HSPCs (average fold difference > 1.5; P < 0.0001). We observed overexpression of AR, ANLN, and SNRPE and down-regulation of NR4A1, CYP27A1, and HLA-A antigen in HRPC progression. AR overexpression is likely to play a central role of hormone-refractory phenotype, and other genes we identified were considered to be related to more aggressive phenotype of clinical HRPCs, and in fact, knockdown of these overexpressing genes by small interfering RNA resulted in drastic attenuation of prostate cancer cell viability. Our microarray analysis of HRPC cells should provide useful information to understand the molecular mechanism of HRPC progression and to identify molecular targets for development of HRPC treatment.
Similar articles
-
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.Cancer Res. 2006 Mar 1;66(5):2815-25. doi: 10.1158/0008-5472.CAN-05-4000. Cancer Res. 2006. PMID: 16510604
-
Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.Prostate. 2003 Sep 1;56(4):280-6. doi: 10.1002/pros.10262. Prostate. 2003. PMID: 12858356
-
Evolution of the androgen receptor pathway during progression of prostate cancer.Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082. Cancer Res. 2006. PMID: 16707422
-
Molecular regulation of androgen action in prostate cancer.J Cell Biochem. 2006 Oct 1;99(2):333-44. doi: 10.1002/jcb.20794. J Cell Biochem. 2006. PMID: 16518832 Review.
-
Androgen receptor action in hormone-dependent and recurrent prostate cancer.J Cell Biochem. 2006 Oct 1;99(2):362-72. doi: 10.1002/jcb.20811. J Cell Biochem. 2006. PMID: 16619264 Review.
Cited by
-
Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes.Heliyon. 2024 Jul 8;10(14):e34322. doi: 10.1016/j.heliyon.2024.e34322. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39108866 Free PMC article. Review.
-
Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer.Cancer Res. 2024 Sep 16;84(18):3004-3022. doi: 10.1158/0008-5472.CAN-23-2910. Cancer Res. 2024. PMID: 38959335
-
Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications.Front Oncol. 2024 May 10;14:1355551. doi: 10.3389/fonc.2024.1355551. eCollection 2024. Front Oncol. 2024. PMID: 38800374 Free PMC article.
-
1,25-Dihydroxyvitamin D3 Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line.Biology (Basel). 2024 May 15;13(5):346. doi: 10.3390/biology13050346. Biology (Basel). 2024. PMID: 38785827 Free PMC article.
-
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach.Biomolecules. 2024 Jan 10;14(1):87. doi: 10.3390/biom14010087. Biomolecules. 2024. PMID: 38254687 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials